Publication | Open Access
BRD4‐IRF1 axis regulates chemoradiotherapy‐induced PD‐L1 expression and immune evasion in non‐small cell lung cancer
61
Citations
53
References
2022
Year
The data showed that BRD4-targeted therapy synergized with chemoradiotherapy and anti-PD-1 antibody by boosting anti-tumour immunity in NSCLC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1